Galantamine-induced QTc prolongation.
Nelson
Matthew W
MW
Buchanan
Robert W
RW
D002800:Cholinesterase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D005702:Galantamine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*
D002800:Cholinesterase Inhibitors; D005702:Galantamine